board of director
"Dr. Peterburg became Interim President and Chief Executive Officer in February 2017 after serving as Chairman of the Board of Directors since January 1, 2015. Dr. Peterburg rejoined Teva’s Board of Directors in 2012, after serving as Teva’s Group Vice President—Global Branded Products from October 2010 until October 2011 and serving on Teva’s Board of Directors from 2009 until July 2010. Previously, he served as President and CEO of Cellcom Israel Ltd. from 2003 to 2005, Director General of Clalit Health Services, the leading healthcare provider in Israel, from 1997 to 2002 and CEO of Soroka University Medical Center, Beer-Sheva, from 1995 to 1997. Dr. Peterburg currently serves on the board of directors of Regenera Pharma Ltd. and from 2012 until February 2017 he served on the board of directors of Rosetta Genomics Ltd. Dr. Peterburg received an M.D. degree from Hadassah Medical School and is board-certified in Pediatrics and Health Services Management. Dr. Peterburg received a doctoral degree in Health Administration from Columbia University and an M.Sc. degree in Information Systems from the London School of Economics. Dr. Peterburg is a professor at the School of Business, Ben-Gurion University. As Interim President and CEO and as an established leader in Israeli healthcare, Dr. Peterburg provides healthcare, pharmaceutical, management and comprehensive operational and business expertise as well as knowledge about Teva and its global operations."